Hangzhou Tigermed Consulting Co Ltd

Common Name
Hangzhou Tigermed Consulting
Country
China (Mainland)
Sector
Healthcare
Industry
Diagnostics & Research
Employees
10,185
Ticker
300347
Exchange
SHENZHEN STOCK EXCHANGE
Description
Hangzhou Tigermed Consulting Co., Ltd., a prominent company in the field of contract research, provides clinical trial services in the biopharmaceutical industry. Its primary function is to facilitate...

Hangzhou Tigermed Consulting's GHG Emissions Data Preview

In 2024, Hangzhou Tigermed Consulting completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Hangzhou Tigermed Consulting has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Hangzhou Tigermed Consulting’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Hangzhou Tigermed Consulting’s data sources below and access millions more through our Disclosure Search.

a. Hangzhou Tigermed Consulting's ESG Report 2024
a. Hangzhou Tigermed Consulting's ESG Report 2024
b. Hangzhou Tigermed Consulting's ESG Report 2022
b. Hangzhou Tigermed Consulting's ESG Report 2022

Insights into Hangzhou Tigermed Consulting's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Hangzhou Tigermed Consulting amounted to 15,214.07 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Hangzhou Tigermed Consulting decreased by 4.91%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

Hangzhou Tigermed Consulting's Scope 1 Emissions Over Time

20202021202220232024055110165220tCO2e-7%+274%+5%0%
  • Total Scope 1
  • Year-over-Year Change

What are Hangzhou Tigermed Consulting's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Hangzhou Tigermed Consulting were 209.63 metric tons of CO₂ equivalent (tCO₂e). a

Has Hangzhou Tigermed Consulting reduced its Scope 1 emissions over time?

Since 2020, Hangzhou Tigermed Consulting's Scope 1 emissions have increased by 267.26%, reflecting a rising long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2023), Hangzhou Tigermed Consulting's Scope 1 emissions remained relatively stable, indicating that Hangzhou Tigermed Consulting's emissions have plateaued with no significant change in its operational footprint. a

What are Hangzhou Tigermed Consulting's Scope 2 emissions?

In 2024, Hangzhou Tigermed Consulting reported Scope 2 greenhouse gas (GHG) emissions of 15,004.44 tCO₂e without specifying the calculation method. a

Has Hangzhou Tigermed Consulting reduced its Scope 2 emissions over time?

Since 2020, Hangzhou Tigermed Consulting's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 1,791.44%, reflecting a rising long-term trend in Scope 2 emissions over time. a b

Compared to the previous year (2023), Hangzhou Tigermed Consulting's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Hangzhou Tigermed Consulting 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Hangzhou Tigermed Consulting use for Scope 2 reporting?

In 2024, Hangzhou Tigermed Consulting reported its Scope 2 emissions using an unspecified methodology. a

Hangzhou Tigermed Consulting's Scope 2 Emissions Over Time

2020202120222023202404 k8 k12 k16 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Hangzhou Tigermed Consulting’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Hangzhou Tigermed Consulting reported Scope 1 greenhouse gas (GHG) emissions of 209.63 tCO₂e and total revenues of USD 905 millions. This translates into an emissions intensity of 0.23 tCO₂e per millions USD. a

Hangzhou Tigermed Consulting's Scope 1 Emissions Intensity Compared to Peers

1020010,000200,00010,000,000Scope 1 Emissions (tCO2e)502002,00010,00050,000Revenues (Millions of USD)CCZCJTInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MSnibeYear: 2023Scope 1: 210 tCO2eRevenue: $M 553Scope 1 Intensity: 0.38 tCO2e/$MJinxin Fertility GroupYear: 2023Scope 1: 1,275 tCO2eRevenue: $M 429Scope 1 Intensity: 2.97 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MCCCR Double-CraneYear: 2023Scope 1: 51,608 tCO2eRevenue: $M 1,438Scope 1 Intensity: 35.88 tCO2e/$MAier Eye Hospital GroupYear: 2024Scope 1: 9,684 tCO2eRevenue: $M 2,875Scope 1 Intensity: 3.37 tCO2e/$MCCCR MedicalYear: 2023Scope 1: 1,359 tCO2eRevenue: $M 1,556Scope 1 Intensity: 0.87 tCO2e/$MMicroport ScientificYear: 2023Scope 1: 3,168 tCO2eRevenue: $M 7,404Scope 1 Intensity: 0.43 tCO2e/$MWuXi AppTecYear: 2024Scope 1: 66,472 tCO2eRevenue: $M 5,377Scope 1 Intensity: 12.36 tCO2e/$MInnovent BiologicsYear: 2023Scope 1: 65 tCO2eRevenue: $M 953Scope 1 Intensity: 0.07 tCO2e/$MJoinn Laboratories ChinaYear: 2023Scope 1: 319 tCO2eRevenue: $M 334Scope 1 Intensity: 0.96 tCO2e/$MZZZhangzhou Pientzehuang PharmaceuticalYear: 2023Scope 1: 2,301 tCO2eRevenue: $M 1,415Scope 1 Intensity: 1.63 tCO2e/$MYunkang GroupYear: 2022Scope 1: 51 tCO2eRevenue: $M 589Scope 1 Intensity: 0.09 tCO2e/$MUnited ImagingYear: 2023Scope 1: 26,821 tCO2eRevenue: $M 1,606Scope 1 Intensity: 16.71 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MCCCSPC Pharmaceutical GroupYear: 2024Scope 1: 474,567 tCO2eRevenue: $M 4,327Scope 1 Intensity: 109.67 tCO2e/$MJJJointown Pharmaceutical GroupYear: 2024Scope 1: 36,924 tCO2eRevenue: $M 20,801Scope 1 Intensity: 1.78 tCO2e/$MSichuan Kelun PharmaceuticalYear: 2024Scope 1: 2,361,763 tCO2eRevenue: $M 2,989Scope 1 Intensity: 790.21 tCO2e/$MTTTong Ren Tang TechnologiesYear: 2024Scope 1: 30,000 tCO2eRevenue: $M 1,086Scope 1 Intensity: 27.62 tCO2e/$MYuwellYear: 2023Scope 1: 2,201 tCO2eRevenue: $M 1,122Scope 1 Intensity: 1.96 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MKingMed DiagnosticsYear: 2023Scope 1: 5,236 tCO2eRevenue: $M 1,202Scope 1 Intensity: 4.36 tCO2e/$MHangzhou Tigermed ConsultingYear: 2024Scope 1: 210 tCO2eRevenue: $M 905Scope 1 Intensity: 0.23 tCO2e/$M

How does Hangzhou Tigermed Consulting's GHG emissions intensity compare to its peers?

In 2024, Hangzhou Tigermed Consulting reported a Scope 1 emissions intensity of 0.23 tCO₂e per millions USD. Compared to the peer group median of 3.37 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Hangzhou Tigermed Consulting rank on GHG emissions intensity within its industry?

In 2024, Hangzhou Tigermed Consulting ranked 5 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Hangzhou Tigermed Consulting among the top performers, with one of the lowest emissions intensities relative to peers. a

Want Full Access to Hangzhou Tigermed Consulting's GHG Emissions Dataset?
Sign Up